BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 38708178)

  • 1. Enzyme-Linked Lipid Nanocarriers for Coping Pseudomonal Pulmonary Infection. Would Nanocarriers Complement Biofilm Disruption or Pave Its Road?
    Nafee N; Gaber DM; Abouelfetouh A; Alseqely M; Empting M; Schneider M
    Int J Nanomedicine; 2024; 19():3861-3890. PubMed ID: 38708178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors.
    Nafee N; Husari A; Maurer CK; Lu C; de Rossi C; Steinbach A; Hartmann RW; Lehr CM; Schneider M
    J Control Release; 2014 Oct; 192():131-40. PubMed ID: 24997276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alginate lyase immobilized chitosan nanoparticles of ciprofloxacin for the improved antimicrobial activity against the biofilm associated mucoid P. aeruginosa infection in cystic fibrosis.
    Patel KK; Tripathi M; Pandey N; Agrawal AK; Gade S; Anjum MM; Tilak R; Singh S
    Int J Pharm; 2019 May; 563():30-42. PubMed ID: 30926526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness.
    Pritchard MF; Powell LC; Jack AA; Powell K; Beck K; Florance H; Forton J; Rye PD; Dessen A; Hill KE; Thomas DW
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing the Thermo-Stability and Anti-Biofilm Activity of Alginate Lyase by Immobilization on Low Molecular Weight Chitosan Nanoparticles.
    Li S; Wang Y; Li X; Lee BS; Jung S; Lee MS
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual bioresponsive antibiotic and quorum sensing inhibitor combination nanoparticles for treatment of Pseudomonas aeruginosa biofilms in vitro and ex vivo.
    Singh N; Romero M; Travanut A; Monteiro PF; Jordana-Lluch E; Hardie KR; Williams P; Alexander MR; Alexander C
    Biomater Sci; 2019 Sep; 7(10):4099-4111. PubMed ID: 31355397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms.
    Armijo LM; Wawrzyniec SJ; Kopciuch M; Brandt YI; Rivera AC; Withers NJ; Cook NC; Huber DL; Monson TC; Smyth HDC; Osiński M
    J Nanobiotechnology; 2020 Feb; 18(1):35. PubMed ID: 32070354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and Genotypic Adaptations in Pseudomonas aeruginosa Biofilms following Long-Term Exposure to an Alginate Oligomer Therapy.
    Oakley JL; Weiser R; Powell LC; Forton J; Mahenthiralingam E; Rye PD; Hill KE; Thomas DW; Pritchard MF
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33472983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailored Nanocarriers for the Pulmonary Delivery of Levofloxacin against Pseudomonas aeruginosa: A Comparative Study.
    Derbali RM; Aoun V; Moussa G; Frei G; Tehrani SF; Del'Orto JC; Hildgen P; Roullin VG; Chain JL
    Mol Pharm; 2019 May; 16(5):1906-1916. PubMed ID: 30900903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of quorum-sensing-dependent virulence factors and biofilm formation of clinical and environmental Pseudomonas aeruginosa strains by ZnO nanoparticles.
    García-Lara B; Saucedo-Mora MÁ; Roldán-Sánchez JA; Pérez-Eretza B; Ramasamy M; Lee J; Coria-Jimenez R; Tapia M; Varela-Guerrero V; García-Contreras R
    Lett Appl Microbiol; 2015 Sep; 61(3):299-305. PubMed ID: 26084709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting quorum sensing in Pseudomonas aeruginosa biofilms: current and emerging inhibitors.
    Jakobsen TH; Bjarnsholt T; Jensen PØ; Givskov M; Høiby N
    Future Microbiol; 2013 Jul; 8(7):901-21. PubMed ID: 23841636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate lyase enhances pathogen eradication by antibiotics.
    Daboor SM; Rohde JR; Cheng Z
    J Cyst Fibros; 2021 Mar; 20(2):264-270. PubMed ID: 32482592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
    Furiga A; Lajoie B; El Hage S; Baziard G; Roques C
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1676-86. PubMed ID: 26711774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron-regulated expression of alginate production, mucoid phenotype, and biofilm formation by Pseudomonas aeruginosa.
    Wiens JR; Vasil AI; Schurr MJ; Vasil ML
    mBio; 2014 Feb; 5(1):e01010-13. PubMed ID: 24496793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Potential Quorum-Sensing Inhibitor for Bronchiectasis Therapy: Quercetin-Chitosan Nanoparticle Complex Exhibiting Superior Inhibition of Biofilm Formation and Swimming Motility of
    Tran TT; Hadinoto K
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).
    Deacon J; Abdelghany SM; Quinn DJ; Schmid D; Megaw J; Donnelly RF; Jones DS; Kissenpfennig A; Elborn JS; Gilmore BF; Taggart CC; Scott CJ
    J Control Release; 2015 Jan; 198():55-61. PubMed ID: 25481442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis.
    Pastor M; Moreno-Sastre M; Esquisabel A; Sans E; Viñas M; Bachiller D; Asensio VJ; Pozo AD; Gainza E; Pedraz JL
    Int J Pharm; 2014 Dec; 477(1-2):485-94. PubMed ID: 25445528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of intravesical targeting of novel quorum sensing inhibitor nanoparticles against
    Vadekeetil A; Chhibber S; Harjai K
    J Drug Target; 2019 Nov; 27(9):995-1003. PubMed ID: 30741037
    [No Abstract]   [Full Text] [Related]  

  • 19. Dry powder inhalation containing muco-inert ciprofloxacin and colistin co-loaded liposomes for pulmonary P. Aeruginosa biofilm eradication.
    Wang J; Guo Y; Lu W; Liu X; Zhang J; Sun J; Chai G
    Int J Pharm; 2024 Jun; 658():124208. PubMed ID: 38723731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of alginate lyase on the gentamicin resistance of Pseudomonas aeruginosa in mucoid biofilms.
    Germoni LA; Bremer PJ; Lamont IL
    J Appl Microbiol; 2016 Jul; 121(1):126-35. PubMed ID: 27061817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.